Qingjiao Liao

699 total citations
17 papers, 535 citations indexed

About

Qingjiao Liao is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Qingjiao Liao has authored 17 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Qingjiao Liao's work include Hepatitis C virus research (7 papers), Viral-associated cancers and disorders (4 papers) and Hepatitis B Virus Studies (4 papers). Qingjiao Liao is often cited by papers focused on Hepatitis C virus research (7 papers), Viral-associated cancers and disorders (4 papers) and Hepatitis B Virus Studies (4 papers). Qingjiao Liao collaborates with scholars based in China and United States. Qingjiao Liao's co-authors include Xulin Chen, Ying Zhu, Linbai Ye, Yang Wu, Ye Li, Qinghua Zhang, Xiangdong Zhu, Yanni Zhang, Xiaoyu Wu and Xiaonan Fang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of General Virology.

In The Last Decade

Qingjiao Liao

17 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingjiao Liao China 11 181 135 110 85 76 17 535
Annette S. Uss United States 11 202 1.1× 102 0.8× 100 0.9× 171 2.0× 55 0.7× 16 586
Ching‐Hsuan Liu Taiwan 16 202 1.1× 122 0.9× 95 0.9× 37 0.4× 88 1.2× 33 597
Anuj Kumar India 15 287 1.6× 110 0.8× 62 0.6× 92 1.1× 41 0.5× 38 553
Javier P. Martínez Spain 14 269 1.5× 134 1.0× 184 1.7× 66 0.8× 141 1.9× 25 744
Muhammad Idrees Pakistan 14 342 1.9× 218 1.6× 166 1.5× 135 1.6× 142 1.9× 68 822
Anggakusuma Germany 15 181 1.0× 221 1.6× 166 1.5× 299 3.5× 156 2.1× 21 783
Nai-Wan Hsiao Taiwan 9 124 0.7× 214 1.6× 88 0.8× 186 2.2× 94 1.2× 10 571
Nora Hilda Rosas-Murrieta Mexico 13 284 1.6× 89 0.7× 87 0.8× 33 0.4× 84 1.1× 37 577
Atsuya Yamashita Japan 20 252 1.4× 292 2.2× 147 1.3× 264 3.1× 219 2.9× 52 973
Kunitada Shimotohno Japan 9 137 0.8× 171 1.3× 85 0.8× 197 2.3× 33 0.4× 9 594

Countries citing papers authored by Qingjiao Liao

Since Specialization
Citations

This map shows the geographic impact of Qingjiao Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjiao Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjiao Liao more than expected).

Fields of papers citing papers by Qingjiao Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingjiao Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjiao Liao. The network helps show where Qingjiao Liao may publish in the future.

Co-authorship network of co-authors of Qingjiao Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Qingjiao Liao. A scholar is included among the top collaborators of Qingjiao Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingjiao Liao. Qingjiao Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liao, Qingjiao, Yuanyuan Zhang, Yu‐Chen Fan, et al.. (2017). Perceptions of Chinese Biomedical Researchers Towards Academic Misconduct: A Comparison Between 2015 and 2010. Science and Engineering Ethics. 38 indexed citations
2.
Kong, Lingbao, Shanshan Li, Qingjiao Liao, et al.. (2013). Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity. Antiviral Research. 98(1). 44–53. 139 indexed citations
3.
Liao, Qingjiao, et al.. (2013). Germacrone inhibits early stages of influenza virus infection. Antiviral Research. 100(3). 578–588. 60 indexed citations
4.
Xiao, Yi, Jungang Chen, Qingjiao Liao, et al.. (2013). Lytic infection of Kaposi’s sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining. Journal of General Virology. 94(8). 1870–1875. 26 indexed citations
5.
Lu, Yimei, et al.. (2012). Fangchinoline Inhibits Human Immunodeficiency Virus Type 1 Replication by Interfering with gp160 Proteolytic Processing. PLoS ONE. 7(6). e39225–e39225. 41 indexed citations
6.
Zeng, Jing, Yang‐Chang Wu, Qingjiao Liao, et al.. (2012). Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner. Antiviral Research. 95(3). 245–256. 27 indexed citations
7.
Zhao, Ling, Kaiyu Wang, Qingjiao Liao, Rui Zhang, & Wei Zhang. (2012). Optimization of Polysaccharides Extraction from the Fruiting Bodies of Catathelasma ventricosum Using Response Surface Methodology. Research Journal of Biological Sciences. 7(1). 43–47. 1 indexed citations
8.
Su, Ling, Qingjiao Liao, Yang Wu, & Xulin Chen. (2011). Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Down-Regulates IL-22R1 Expression through a Cis-Acting Element within the Promoter Region. PLoS ONE. 6(4). e19106–e19106. 7 indexed citations
9.
Cai, Weijia, Liya Su, Qingjiao Liao, et al.. (2010). Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast. Antiviral Research. 88(1). 80–85. 12 indexed citations
10.
Wu, Yang‐Chang, et al.. (2010). A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication. Virus Research. 155(2). 406–414. 24 indexed citations
11.
Zhou, Xia, Qingjiao Liao, Robert P. Ricciardi, Can Peng, & Xulin Chen. (2010). Kaposi’s sarcoma-associated herpesvirus processivity factor-8 dimerizes in cytoplasm before being translocated to nucleus. Biochemical and Biophysical Research Communications. 397(3). 520–525. 9 indexed citations
12.
She, Yinglong, Qingjiao Liao, Xulin Chen, Linbai Ye, & Zhenghui Wu. (2008). Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity. Archives of Virology. 153(11). 1991–1997. 8 indexed citations
13.
Tian, Ren‐Rong, Qingjiao Liao, & Xulin Chen. (2008). Prevention and treatment of KSHV-associated diseases with antiviral drugs. Virologica Sinica. 23(6). 486–495. 2 indexed citations
14.
Tian, Ren‐Rong, Qingjiao Liao, & Xu‐Lin Chen. (2007). Current status of targets and assays for anti-HIV drug screening. Virologica Sinica. 22(6). 476–485. 4 indexed citations
15.
Yang, Xiaojun, Jing Liu, Ye Li, et al.. (2006). HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression. Virus Research. 121(2). 134–143. 38 indexed citations
16.
Timani, Khalid Amine, Qingjiao Liao, Linbai Ye, et al.. (2005). Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Research. 114(1-2). 23–34. 83 indexed citations
17.
Liao, Qingjiao. (2005). Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-κB activation. World Journal of Gastroenterology. 11(41). 6433–6433. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026